药房市场规模、份额和成长分析（按药房、产品供应、可及性、药物类型、药物分子类型和地区划分）－2026-2033年产业预测

预计到 2024 年，全球医药市场规模将达到 1.25 兆美元，到 2025 年将达到 1.34 兆美元，到 2033 年将达到 2.36 兆美元，在预测期（2026-2033 年）内，复合年增长率为 7.3%。

由于慢性病盛行率上升、医疗保健需求不断增长以及药物研发和技术进步，全球药房市场正在快速发展。个人化医疗的需求显着增加，学名药日益普及，线上药局也蓬勃发展。儘管存在这些积极趋势，但该行业仍面临着许多挑战，例如严格的监管要求、高昂的研发成本以及价格压力。然而，也存在着许多机会，包括数位健康解决方案和远端医疗服务的成长、对预防保健的日益重视以及发展中地区市场的快速成长。透过适应这些变化的环境和消费者需求，药房产业有望实现显着成长。

推动全球药局市场发展的因素

生物技术的进步正推动着针对各种健康状况的更可靠、更有效的药物的研发，尤其是在生物相似药和生物製药领域。此外，个人化基因资讯日益重要，也带动了对个人化药物和医疗产品的需求。这些发展，加上患者对更精准、更有效的治疗方案的需求不断变化，正推动着全球药房市场显着增长，而个人化医疗的日益普及正是这一增长的主要驱动力。因此，药房市场正经历着变革时期。

限制全球医药市场的因素

研发和上市新药的高昂成本会阻碍中小企业进入市场，并限制整个製药业的成长。研发和监管核准所需的大量投资构成准入壁垒，限制了竞争和创新。此外，许多候选药物在临床试验阶段失败，对相关公司造成重大经济损失。这些高成本，加上结果的不确定性，为中小企业带来了严峻的挑战，最终影响全球医药市场的格局。

全球医药市场趋势

在全球基因组检测和标靶治疗进步的推动下，全球医药市场正经历着向个人化医疗的重大转变。这种转变在慢性病和肿瘤治疗领域尤其明显，个人化治疗方案在这些领域的重要性日益凸显。此外，生物相似药和生物製药的兴起为复杂的健康状况提供了更多个人化的治疗选择，并改善了患者的整体预后。随着精准医疗在医疗保健领域的重要性日益凸显，对个人化医疗的需求预计将进一步增长，这将重塑药学实践，并扩大药剂师在患者照护中的作用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术分析

全球药局市场规模：依药局类型及复方年增长率划分（2026-2033 年）

• 零售药房
• 网路药房
• 医院药房
• 其他药房

全球药局市场规模（依产品供应量及复合年增长率划分）（2026-2033 年）

• 药品/製剂
• 医疗设备
• 其他药房产品

全球药局市场规模：按类型分類的供应情况及复合年增长率（2026-2033 年）

• 处方笺药
• 非处方药

全球药局市场规模（依药品类型及复方年增长率划分）（2026-2033 年）

• 品牌药/专利药
• 学名药

全球药局市场规模（依药物分子类型划分）及复合年增长率（2026-2033 年）

• 小分子药物
• 生物製药

全球药局市场规模（按网路药局平台类型和复合年增长率划分）（2026-2033 年）

• 基于应用程式的平台
• 网路为基础的平台

全球药局市场规模（依治疗领域划分）及复合年增长率（2026-2033 年）

• 肿瘤性疾病
• 循环系统疾病
• 神经系统疾病
• 感染疾病
• 代谢性疾病
• 呼吸系统疾病
• 皮肤病
• 遗传性疾病
• 自体免疫疾病/发炎性疾病
• 其他疾病

全球药局市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• CVS Health Corporation（USA）
• AmerisourceBergen Corporation（USA）
• McKesson Corporation（USA）
• Cardinal Health, Inc.（USA）
• Rite Aid Corporation（USA）
• OptumRx, Inc.（USA）
• Humana Inc.（USA）
• Groupe Pharmagest SA（France）
• MedImpact Healthcare Systems, Inc.（USA）
• AllianceRx Walgreens Prime（USA）
• Benzer Pharmacy（USA）
• Kroger Health（USA）
• HealthWarehouse.com, Inc.（USA）

结论与建议

Global Pharmacy Market size was valued at USD 1.25 Trillion in 2024 and is poised to grow from USD 1.34 Trillion in 2025 to USD 2.36 Trillion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global pharmacy market is rapidly evolving, fueled by the increasing prevalence of chronic illnesses, heightened healthcare demands, and advancements in pharmaceutical research and technology. There is a substantial rise in the need for personalized medications, the popularity of generic drugs, and the expansion of online pharmacies. Despite these positive trends, the industry faces challenges including strict regulatory requirements, high research and development costs, and pricing pressures. Nonetheless, opportunities abound, particularly with the growth of digital health solutions and telehealth services, an increasing focus on preventive care, and a burgeoning market in developing regions. The pharmacy sector is poised for significant growth as it adapts to these changing dynamics and consumer needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacy Market Segments Analysis

Global Pharmacy Market is segmented by Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of E-PharmacyPlatform, Therapeutic Area and region. Based on Pharmacy, the market is segmented into Retail Pharmacy, e-pharmacy, Hospital Pharmacy and Other Pharmacies. Based on Product Offered, the market is segmented into Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products. Based on Availability, the market is segmented into Prescription Products and Over-the-counter Products. Based on Type of Drug, the market is segmented into Branded / Patented Drugs and Generic Drugs. Based on Type of Drug Molecule, the market is segmented into Small Molecules and Biologics. Based on Type of e-pharmacy Platform, the market is segmented into App-based Platforms and Web-based Platforms. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmacy Market

Advancements in biotechnology are leading to an increase in drug developments, particularly in the areas of biosimilars and biologics, which demonstrate enhanced reliability and effectiveness for various health conditions. Additionally, the rising significance of personalized genetic information is influencing the demand for tailored medications and healthcare products. These developments are driving substantial growth in the global pharmacy market, as a greater focus on individualized treatment options aligns with the evolving needs of patients seeking more precise and effective therapeutic solutions. As such, the pharmacy market is experiencing a transformative phase marked by innovation and customization.

Restraints in the Global Pharmacy Market

The high expenses associated with the development and launch of new pharmaceuticals can deter smaller companies from entering the market, potentially hindering overall growth within the pharmaceutical sector. The substantial investment required for research, development, and regulatory approval can be a barrier to entry, limiting competition and innovation. Additionally, the reality that a significant percentage of drug candidates fail during clinical trials results in considerable financial setbacks for companies involved. This combination of high costs and uncertain outcomes creates a challenging environment for smaller players, ultimately affecting the dynamics of the global pharmacy market.

Market Trends of the Global Pharmacy Market

The global pharmacy market is witnessing a significant trend towards personalized medicine, driven by advancements in genomics testing and targeted therapies. This shift is particularly prominent in the management of chronic diseases and oncology, where individualized treatment approaches are becoming increasingly essential. Furthermore, the rise of biosimilars and biologics is enhancing the availability of tailored treatment options, catering to complex health conditions and improving overall patient outcomes. As healthcare increasingly prioritizes precision medicine, the demand for customized therapies is expected to grow, reshaping pharmacy practices and expanding the role of pharmacists in patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Pharmacy Market Size by Pharmacy & CAGR (2026-2033)

• Market Overview
• Retail Pharmacy
• e-pharmacy
• Hospital Pharmacy
• Other Pharmacies

Global Pharmacy Market Size by Product Offered & CAGR (2026-2033)

• Market Overview
• Drugs / Pharmaceuticals
• Medical Devices
• Other Pharmacy Products

Global Pharmacy Market Size by Availability & CAGR (2026-2033)

• Market Overview
• Prescription Products
• Over-the-counter Products

Global Pharmacy Market Size by Type of Drug & CAGR (2026-2033)

• Market Overview
• Branded / Patented Drugs
• Generic Drugs

Global Pharmacy Market Size by Type of Drug Molecule & CAGR (2026-2033)

• Market Overview
• Small Molecules
• Biologics

Global Pharmacy Market Size by Type of e-pharmacy Platform & CAGR (2026-2033)

• Market Overview
• App-based Platforms
• Web-based Platforms

Global Pharmacy Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncological Disorders
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Disorders
• Dermatological Disorders
• Genetic Disorders
• Autoimmune / Inflammatory Disorders
• Other Disorders

Global Pharmacy Market Size & CAGR (2026-2033)

• North America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • US
  • Canada
• Europe (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CVS Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rite Aid Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptumRx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groupe Pharmagest S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImpact Healthcare Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllianceRx Walgreens Prime (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benzer Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kroger Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthWarehouse.com, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations